Delivery Order SPE2DE24D0013-SPE2D625F0BYW
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The Department of Defense's Medical Supply Chain awarded a $1,699.50 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order, designated XPRSARS-COV2-DOD, carries no set-aside designation and represents a continuation of Cepheid's established role as a federal supplier of diagnostic equipment and testing solutions. The contract...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,104 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award builds upon Cepheid's extensive track record providing molecular diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense agency's Medical Supply Chain issued a delivery order valued at $4,901.39 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract number GXCT/NG-10. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid specializes in providing advanced molecular...
- The Defense Logistics Agency awarded a $19.25K delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer based in Sunnyvale, California, under a firm fixed-price contract with an ultimate completion date of August 6, 2025. This non-set-aside delivery order (Contract No. 4568946540, designated XPRSARS-COV2-10) procures molecular diagnostic solutions, consistent with Cepheid's core business of providing advanced diagnostic systems and test kits for infectious diseases, including...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,968.00 firm fixed-price delivery order to Cepheid Inc. on August 4, 2025, for molecular diagnostic solutions with an ultimate completion date of August 18, 2025. This delivery order, which carries no set-aside designation, is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts with the Veterans Integrated Service Networks, such as the $32.8M IDV with VA VISN 6 or the $2.5M IDV with VA VISN...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0BYWDelivery Order
The U.S. Defense Department's Medical Supply Chain has awarded a $5,082 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2 testing supplies. The contract, awarded on August 4, 2025, with an ultimate completion date of August 18, 2025, carries no set-aside designation and will be performed at Cepheid's primary facility in Sunnyvale. This delivery order falls under Cepheid's existing indefinite delivery vehicle relationships with the Veterans Administration, which has established the company as a qualified provider of molecular diagnostic solutions across federal healthcare systems. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19, influenza, RSV, and other clinical conditions, serving multiple federal agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company maintains significant IDV contracts with VA networks, including a $32.8 million vehicle through September 30, 2030, supporting the department's ongoing requirements for molecular diagnostic testing reagents and assays. This award reflects the continued reliance of federal defense health operations on Cepheid's diagnostic capabilities to support pandemic preparedness and routine infectious disease detection across military healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/4/25 |